Veterans Administration Drug Lipid Cooperative Study Group
This content is PDF only. Please click on the PDF icon to access.
Five hundred seventy male veterans, average age 51 years, with documented transmural myocardial infarction occurring within a 12-month period, were randomized into groups receiving placebo, estrogen (1.25 mg Premarin® per day), dextrothyroxine (4 mg/day), aluminum nicotinate (Nicalex® 4 g/day), combined estrogen and nicotinate (full dosage of Premarin plus Nicalex), or combined estrogen and dextrothyroxine (full dosage of Premarin plus dextrothyroxine). Follow-up was 5 years; the interval between visits, 2 months. Adherence was carefully monitored. Dietary or smoking modifications were not stressed. Average baseline cholesterol was 241 mg/100 ml. Estrogen had no effect on cholesterol levels. Maximal drop in cholesterol was
Learn more about subscription options.
Register Now for a free account.
Veterans Administration Drug Lipid Cooperative Study Group. Failure of Cholesterol-Lowering Drugs to Influence Coronary Mortality: A Double Blind 5-Year Secondary Prevention Study.. Ann Intern Med. 1972;76:868. doi: 10.7326/0003-4819-76-5-868_3
Download citation file:
Published: Ann Intern Med. 1972;76(5):868.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only